FDA Science Board Will Double Membership And Meetings
This article was originally published in The Gray Sheet
Executive Summary
FDA Commissioner Andrew von Eschenbach wants to increase the impact of the agency's Science Board by doubling the number of members and meetings
You may also be interested in...
A Matter Of $275 Million: Congress And White House Tussle Over FDA Funds
The Bush Administration tried to get ahead of Congress' relentless criticism that it is under-funding FDA last week by adding $275 million for the agency to its fiscal year 2009 budget request. Critics on Capitol Hill were not impressed
FDA Scientific Capacity Inadequate; New Device Technology At Risk
CDRH is not equipped to understand the science behind many cutting-edge device technologies, says a Nov. 29 report from the Subcommittee on Science and Technology, an ad hoc panel of the FDA Science Board
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.